Articles by Disease (Osteosarcoma)

Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine

Journal: Current Drug Metabolism
Volume: 14
Page: 547-564
Author(s): Jana Drbohlavova, Jana Chomoucka, Vojtech Adam, Marketa Ryvolova, Tomas Eckschlager, Jaromir Hubalek and Rene Kizek

Pharmacokinetics and Pharmacodynamics of Oseltamivir in Neonates, Infants and Children

Journal: Infectious Disorders - Drug Targets
Volume: 13
Page: 6-14
Author(s): Joseph F. Standing, Maria Tsolia and Irja Lutsar

Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy

Journal: Current Cancer Drug Targets
Volume: 13
Page: 486-499
Author(s): Gagan Deep and Rajesh Agarwal

Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases

Journal: Current Drug Targets
Volume: 14
Page: 919-935
Author(s): Ramya Krishna Vadlapatla, Aswani Dutt Vadlapudi and Ashim K. Mitra

Traditional Chinese Medicine Remedy to Jury: The Pharmacological Basis for the Use of Shikonin as an Anticancer Therapy

Journal: Current Medicinal Chemistry
Volume: 20
Page: 2892-2898
Author(s): I. Andujar, M. C. Recio, R. M. Giner and J. L. Ríos

Deep Penetration of Nanoparticulate Drug Delivery Systems into Tumors: Challenges and Solutions

Journal: Current Medicinal Chemistry
Volume: 20
Page: 2881-2891
Author(s): L. Li, J. Sun and Z. He

Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?

Journal: Current Medicinal Chemistry
Volume: 20
Page: 2868-2880
Author(s): D. Nikitovic, A. Berdiaki, A. Banos, A. Tsatsakis, N. K. Karamanos and G. N. Tzanakakis